headlinez.news Live news trend intelligence
◼ Archived Health 🔮 headlinez.news predicts: fades by tomorrow — graded ✓ correct

Heart disease in women: Women with THIS common hormonal condition are at higher risk, new study finds

A newly published Lancet study reclassifies PCOS as PMOS and links the hormonal condition to an increased risk of heart disease in women.

4sources
4articles
2velocity
+0%since first seen
45d agofirst detected
Visual summary for Heart disease in women: Women with THIS common hormonal condition are at higher risk, new study finds
headlinez.news visual summary

Answered

What is the new name for the condition previously known as PCOS?

The condition is now referred to as PMOS, or Premenstrual Ovary Syndrome.

What health risk is associated with PMOS?

A recent study in The Lancet indicates that women with PMOS are at a higher risk for heart disease.

How common is PMOS?

According to reports, the condition affects one in eight women globally.

Where it stands

A medical study published in The Lancet has identified a link between a common hormonal condition and a heightened risk of heart disease in women. The research coincides with a formal name change for the condition, transitioning from Polycystic Ovary Syndrome (PCOS) to Premenstrual Ovary Syndrome (PMOS).

Coverage from The Times of India, The Week, and SNJ Today emphasizes the scale of the condition, noting it affects one in eight women globally. Medical Dialogues also highlighted these findings in its recent medical bulletin.

Future updates will likely monitor clinical guidance following the rebranding. Coverage does not yet specify if the name change will impact diagnostic criteria or treatment protocols.

Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 43d ago.

Who reported it (4)

Momentum

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Topics

Related trends

◼ Archived Health 🔮 fades ✓

Why it took so long to talk about perimenopause

New global reviews and expert guidance finally break the silence on perimenopause, turning years of stigma into a science‑driven conversation.

4 sources 4 articles v 2 43d ago
◼ Archived Business 🔮 fades ✗

We’re beating heart disease

FDA greenlights the first oral pill that could replace cholesterol injections, sparking both hope and caution.

8 sources 8 articles v 6 44d ago